Abstract
Leptin is a peptide hormone that has an essential role in the regulation of body weight by inhibiting food intake and stimulating energy expenditure. The role of leptin in the modulation of the immune response and inflammation has been regarded as important. In rheumatoid arthritis (RA) patients it was reported that fasting leads to an improvement of clinical and biological measures of disease activity, which was associated with a marked decrease in serum leptin. These features suggest that leptin may also influence the inflammatory mechanisms of arthritis in humans. In this study we assessed serum leptin levels in RA and osteoarthritis (OA) patients and found a correlation between serum leptin level and other markers as well as bone mass density changes, activity of disease, disease duration and the age of the patients. The blood was collected from 30 RA and 30 OA patients who constituted the control group. Serum leptin level was determined using the DRG Leptin ELISA Kit—a solid phase enzyme—linked immunosorbent assay based on the sandwich principle. The serum level of leptin in RA patients ranged from 1.8 to 81.1 ng/ml and median value was 11.2. There was a positive correlation between body mass index (BMI) of RA patients and serum level of leptin (correlation coefficients Spearman’s r = 0.81). According to correlation coefficients, serum leptin level is independent of age of RA patients, stage of disease, number of painful and swollen joints, duration of morning stiffness, disease duration as well as value of titre of the Waaler–Rose, disease activity score (DAS 28) value and presence of rheumatoid nodules. There was a negative correlation between serum leptin level and glomerular filtration rate (GFR). No correlation between the serum leptin level and T-score was found. An influence of steroid treatment on the serum leptin level was not shown. The median serum leptin level in OA patients was 9.2 ng/ml. There was a positive correlation between body mass index of OA patients and serum level of leptin (correlation coefficients Spearman’s r = 0.57). No correlation was found between serum leptin level and patient’s age, duration of disease and value of laboratory data. There were no correlations between serum leptin level and visual analogue pain scale (VAS) for the lower-limb afflicted patients as well as stage of disease according to Kellgren and Lawrence’s score in OA patients. There was a negative correlation between serum leptin level and T-score value in OA patients (r = −0.58, P < 0.05). No statistically significant differences were found between serum leptin levels for RA and OA patients.
Similar content being viewed by others
References
Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413–437
Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and, hematopoiesis. J Leukoc Biol 68:437–446
Lord GM, Matarese G, Howard JK et al (1998) Leptin modulates the T-cell immune response and reserves starvation-induced immunosuppression. Nature 394:897–901
Busso N, So A, Chobaz-Peclat V et al (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 169:875–872
Howard JK, Lor GM, Matarese G et al (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob./ob. mice. J Clin Invest 104:1051–1059
Flier JS (1998) Lowered leptin slims immune response. Nat Med 4:1124–1125
Farooqi IS, Matarese G, Lord GM et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093–1103
Saraf P, Fantuzzi G, Fuler J et al (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185:171–175
Faggioni R, Fantuzzi G, Fuler J et al (1998) Il-1 beta mediates leptin induction during inflammation. Am J Physiol 274:R 204–208
Loffreda S, Yang SQ, Lin HZ et al (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:577–65
Gabay C, Dreyer M, Pellegrineli N et al (2001) Leptin directly induces the secretion of interleulin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86:783–791
Takahashi N, Waelput W, Guisez Y (1999) Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 189:207–212
Fraser DA, Thoen J, Reseland JE et al (1999) Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18:394–401
Arnett FC (1989) Revised criteria for the classification of rheumatoid arthritis. Bul Rheum Dis 38:1–6
Steinbrocker O, Treger H, Cornelius H (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
Larsen A, Dale K, Eek M (1977) Radiographic eveluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 18:481–491
Van der Heijde DMFM, van’t Hof MA, van Riel PLCM et al (1993) Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 20:579–581
Altman R (1991) Classification of disease:osteoarthritis. Semin Arthritis Rheum 21(Suppl 2):40–47
Bellamy N, Buchanan WW, Goldsmith CH, et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840
Kellgren JH, Lawrence SJ (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502
Conside RV, Sinha MK, Heiman ML (1996) Serum immunoreactive—leptin concentrations in normal weight and obese humans. New Engl J Med 334:292–295
Robert R, Sokal F, Rohlf J (1986) Biometry. Freeman, New York, pp 354–359, 691–714
Gainsford T, Willson TA, Metcalf D et al (1996) Leptin can induce proliferation, differentiation and functional activation of hemopoeitic cells. Proc Natl Acad Sci USA 93:14564–14568
Charles P, Elliott MJ, Davis D (1999) Regulation of cytokines, cytokine inhibitors and acute-phase proteins folowing anti-TNF alpha therapy in rheumatoid arthritis. J Immunol 163:1521–1528
Roubenoff R, Roubenoff RA, Ward LM et al (1994) Rheumatoid cachexia; cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 93:2379–2389
Sarraf P, Frederich RC, Turner EM (1997) Multiple cytokines and acute inflammation raise mouse leptin levels. Potential role in inflammatory anorexia. J Exp Med 185:171–175
Anders HJ, Rihl M, Heufelder A et al (1999) Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48:745–748
Nishiya K, Nishiiyama M, Chang A et al (2002) Serum leptin in patients with rheumatoid arthritis are correlated with body mass index. Abstract Rinshobyori 50:524–527
Tokarczuk-Knapik A, Nowicki M, Wyroslak J (2002) The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wewn 108:761–767
Bokarewa M, Bokarew D, Hultgren O et al (2003) Leptin consumption in the inflammed joits of patients with rheumatoid arthritis. Ann Rheum Dis 62:952–956
Dumond H, Presle N, Terlain B (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 11:3118–3129
Rubin CT, Lanyon LE (1985) Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37:411–417
Albala C, Yanez M, Devoto E et al (1996) Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes 20:1027–1032
Reid IR, Ames R, Evans M et al (1992) Determinants of total body and regional bone mineral density in normal postmenopausal women—a key role for fat mass. J Clin Endocrinol Metab 75:45–51
Bai Y, Zhang S, Kim LS et al (1996) Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 271:13939–13942
Aubin JE, Turksen K, Heershe JNM (1993) Osteoblastic cell linkage (w) Celular and molecular biology of bone, (red) M. Noda, Academic Press, New York, pp 1–45
Thomas T, Gori F, Khosla S et al (1999) Leptin acts on human marrow stromal cels to enhance differentiation to osteoblast and to inhibit differentiation to adipocytes. Endocrinology 140:1630–1638
Ducy P, Amling M, Taskeda S et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207
Matkovic V, Ilich J, Skugor M et al (1997) Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 82:3239–3245
Gulding A, Taylor RW (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456–458
Odabasi E, Ozata M, Turan M et al (2000) Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170–173
Rauch F, Blum WF, Klein K et al (1998) Does leptin have an effect on bone in adult women? Calcif Tissue Int 63:453–455
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wisłowska, M., Rok, M., Jaszczyk, B. et al. Serum leptin in rheumatoid arthritis. Rheumatol Int 27, 947–954 (2007). https://doi.org/10.1007/s00296-007-0335-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0335-4